https://ctv.veeva.com/study/utaa17-injection-in-the-treatment-of-relapsed-refractory-multiple-myeloma
UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
The clinical trial was designed as a single-arm, open-label clinical study, with the main purpose of exploring the safety, pharmacokinetics, and best...
in theinjectiontreatmentrelapsedrefractory